Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients

被引：6
|
作者：
Niparuck, Pimjai [1 ]
Kanoksil, Wasana
Chuncharunee, Suporn [1 ]
Boonsakan, Paisarn
Ungkanont, Artit [1 ]
Angchaisuksiri, Pantep [1 ]
Karntisaviwat, Kanlaya [2 ]
Apilugsanachit, Axara [2 ]
Rerkamnuatchoke, Budsaba [2 ]
Jootar, Saengsuree [1 ]
Nitiyanant, Prawat
Atichartakarn, Vichai [1 ]
机构：
[1] Mahidol Univ, Div Hematol, Dept Med, Ramathibodi Hosp, Bangkok 10700, Thailand
[2] Mahidol Univ, Dept Pathol, Ramathibodi Hosp, Div Human Genet, Bangkok 10700, Thailand
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 11期
关键词：
RITUXIMAB;
D O I：
10.3109/10428194.2010.505675
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2120 / 2125
页数：6
相关论文
共 50 条
  • [21] Therapy-related acute myelogenous leukemia and myelodysplastic syndrome
    Borthakur G.
    Estey E.E.
    Current Oncology Reports, 2007, 9 (5) : 373 - 377
  • [22] Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy
    Coso, D
    Costello, R
    Cohen-Valensi, R
    Sainty, D
    Nezri, M
    Gastaut, JA
    Bouabdallah, R
    ANNALS OF ONCOLOGY, 1999, 10 (03) : 362 - 363
  • [23] Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication
    Fordham, Sarah E.
    Marr, Helen
    Allan, James M.
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 447 - 448
  • [24] Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine
    Ricardo García-Muñoz
    Diana K. García
    Verónica Roldán-Galiacho
    Miriam Merchante-Andreu
    Andrea Campeny-Najara
    Pilar Rabasa
    Annals of Hematology, 2014, 93 : 699 - 702
  • [25] Risk, overall survival, and prognostic analysis of therapy-related acute myeloid leukemia in non-Hodgkin lymphoma survivors.
    Joshi, Utsav
    Gaire, Suman
    Bhattarai, Adheesh
    Agrawal, Vishakha
    Poudyal, Bishesh Sharma
    Bhatt, Vijaya Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] THERAPY-RELATED LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    KANTARJIAN, HM
    KEATING, MJ
    SEMINARS IN ONCOLOGY, 1987, 14 (04) : 435 - 443
  • [27] Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Cerhan, JR
    Vachon, CM
    Habermann, TM
    Ansell, SM
    Witzig, TE
    Kurtin, PJ
    Janney, CA
    Zheng, W
    Potter, JD
    Sellers, TA
    Folsom, AR
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1466 - 1471
  • [28] Therapy-related myelodysplastic syndrome and acute myeloid leukemia after treatment for Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
    Thielen, I
    Eichenauer, D. A.
    Haverkamp, H.
    Franklin, J.
    Behringer, K.
    Halbsguth, T.
    Fuchs, M.
    Engert, A.
    Borchmann, P.
    ONKOLOGIE, 2012, 35 : 8 - 9
  • [29] Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)
    G Garcia-Manero
    HM Kantarjian
    S Kornblau
    E Estey
    Leukemia, 2002, 16 : 1888 - 1888
  • [30] Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)
    Garcia-Manero, G
    Kantarjian, HM
    Kornblau, S
    Estey, E
    LEUKEMIA, 2002, 16 (09) : 1888 - 1888
12345